Registered entities
Thrombolex, Inc.
Reg. No. 1703764United States
Innovation
3 patent families (3 granted) — focus: Human necessities; filing pace slowing. Cited 331 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Social engagement
Social engagement: 2.7K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
2 investors on record; lead investors include Orbimed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Recent activity
15 Jun 2026
Product launch
BASHIR® Endovascular Device
12 Jun 2026
Product launch
BASHIR® Endovascular Device expandable infusion basket
9 Jun 2026
Product launch
BASHIR® Plus Endovascular Device